Stay updated on Avelumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Solid Tumors Clinical Trial page.

Latest updates to the Avelumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status now shows that no participants are being sought ('No longer looking for participants'), and new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') have been added. The Intervention/Treatment label formatting was updated and the revision version bumped to v3.6.0.SummaryDifference0.2%

- Check17 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor update to the site. The study content and data are unchanged.SummaryDifference0.0%

- Check38 days agoChange DetectedThe revision tag on the page was bumped from v3.5.3 to v3.5.4, marking a minor update to the page’s version metadata.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a small update to the page's version metadata rather than a substantive change to the study details or layout.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded Adrenal cortex carcinoma and Squamous cell carcinoma of the head and neck to the study page’s condition list, aligning with ACC and HNSCC expansion cohorts.SummaryDifference0.0%

Stay in the know with updates to Avelumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Solid Tumors Clinical Trial page.